ARCHIVES

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

This article is from The Cancer Letter archive.

Vol. 14 No. 33 | August 12, 1988

Download PDF Visit The Full Archive

Related Articles

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

DCT Board Approves New RFA For Aids Clinical Trials Groups

November 11, 1994

ACS To Offer 10 Nurse Scholarships

July 18, 1980

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

In Brief: MSK Opens Campaign On Colorectal Cancer Early Detection NIH Symposium Dedicates Cyclotron

August 28, 1987

New Center Plan Discussed By NAB, Directors Committees

May 4, 1990